Sunday, April 19, 2015 4:37:04 PM
I am curious to see how this plays out. Enox approval caused a large % spike followed by a quick plummet. With copax approval, thus far its been a small % spike but preceded by a slow, gradual but substantial rise (mid 10's to mid 16's over 2-3 months).
Even if MYL gets a approval eventually, why wouldn't the market start ascribing a non material value to the rest of the pipeline? MNTA's achievements to date have been ground breaking, and that should count for something. Investing is a forward looking game, after all. There some non newbie biotech investors (hey jbog) who think this is as good as it gets for MNTA. We'll see if the market agrees over the next few weeks, months. Based on what has just happened though, no idea how anyone could reach that conclusion.
I will readily admit that I am quite surprised by what happened last week, and that for the first time in a long time, I am genuinely excited and optimistic about MNTA's future prospects. It's been a long, tough, painful road.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM